- Report
- June 2024
- 150 Pages
Global
From €5483EUR$5,950USD£4,636GBP
- Report
- March 2025
- 200 Pages
Global
From €2295EUR$2,490USD£1,940GBP
- Report
- March 2025
- 200 Pages
Global
From €2295EUR$2,490USD£1,940GBP
- Report
- March 2025
- 200 Pages
Global
From €2295EUR$2,490USD£1,940GBP
- Report
- March 2025
- 200 Pages
Global
From €2295EUR$2,490USD£1,940GBP
- Report
- July 2024
Global
From €4562EUR$4,950USD£3,857GBP
From €4562EUR$4,950USD£3,857GBP
- Report
- April 2025
- 175 Pages
Global
From €4138EUR$4,490USD£3,499GBP
- Report
- April 2025
- 175 Pages
Global
From €4138EUR$4,490USD£3,499GBP
- Report
- March 2025
- 175 Pages
Global
From €4138EUR$4,490USD£3,499GBP
- Report
- February 2025
- 200 Pages
Global
From €4138EUR$4,490USD£3,499GBP
- Report
- May 2025
- 383 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 279 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 272 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 89 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 92 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 91 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 92 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- May 2025
- 258 Pages
Global
From €5391EUR$5,850USD£4,558GBP
- Report
- April 2025
- 175 Pages
Global
From €4138EUR$4,490USD£3,499GBP

The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more